Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin management during pacemaker implantation
2005-000390-22Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Jan 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of warfarin and aspirin in Conditions requiring chronic anticoagulation and Conditions requiring antiplatelet therapy (2 arms), sponsored by Turku University Hospital. Primary endpoint: Clinically significant bleeding. Started Jan 2005; status: completed.
02
Drugs
warfarinaspirin
03
Conditions
Conditions requiring chronic anticoagulationConditions requiring antiplatelet therapy
Beyond the preview
Go deeper on 2005-000390-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000390-22.